DEUTSCHE BANK AG\ - GT BIOPHARMA INC ownership

GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209. A total of 51 filers reported holding GT BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of GT BIOPHARMA INC
ValueSharesWeighting
Q1 2022$31,000
-16.2%
10,824
-9.5%
0.00%
Q4 2021$37,000
-51.9%
11,962
+4.9%
0.00%
Q3 2021$77,000
-67.5%
11,400
-25.7%
0.00%
Q2 2021$237,00015,3490.00%
Other shareholders
GT BIOPHARMA INC shareholders Q2 2021
NameSharesValueWeighting ↓
Baskin Financial Services Inc. 151,354$360.00%
Moss Adams Wealth Advisors LLC 20,000$4,8220.00%
UBS Group AG 8,750$2,1090.00%
Compagnie Lombard Odier SCmA 50,000$12,0550.00%
OSAIC HOLDINGS, INC. 1,270$3050.00%
FMR LLC 150$360.00%
BANK OF AMERICA CORP /DE/ 508$1220.00%
WELLS FARGO & COMPANY/MN 300,697$72,4980.00%
NORTHERN TRUST CORP 32,347$7,7990.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of GT BIOPHARMA INC shareholders